BIOMAT Database Logo BIOMAT Database Logo

Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. 1996

G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Laboratory of Cellular and Tissue Immunology, Hospital Pitié-Salpétriére, Paris, France. ghaas@ccr.jussieu.fr

The vigorous CTL response directed against HIV is considered to be important in reducing HIV viral load, although it is unable to stop ongoing viral replication, which generates new antigenic variants. We analyzed the impact of sequential changes in five epitopes of HIV-1 Nef on CTL recognition in four stable patients. A high rate of variation was found, and in all these patients we could detect CTL specific for 32 out of 36 autologous viral variants occurring in 5 HLA-A2- or HLA-B7-restricted Nef epitopes at two time points. Two distinct patterns for dynamics of CTL responses to viral variation were observed: 1) temporary amplification of viral variants followed by expansion of variant-specific CTL, ultimately leading to the disappearance of 12 out of the 14 initial epitope variants within two years. A second set of viral variants that had replaced the initial ones could also stimulate specific CTL precursors in the context of the same or an alternative HLA molecule; and 2) persistence of 2 viral variants in relatively conserved epitopes despite specific CTL recognition. Therefore, a remarkable flexibility of the immune system allows constant adaptation of CTL to multiple HIV variants and thus elimination of HIV variant-producing cells in slow progressors.

UI MeSH Term Description Entries
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000940 Antigenic Variation Change in the surface ANTIGEN of a microorganism. There are two different types. One is a phenomenon, especially associated with INFLUENZA VIRUSES, where they undergo spontaneous variation both as slow antigenic drift and sudden emergence of new strains (antigenic shift). The second type is when certain PARASITES, especially trypanosomes, PLASMODIUM, and BORRELIA, survive the immune response of the host by changing the surface coat (antigen switching). (From Herbert et al., The Dictionary of Immunology, 4th ed) Antigen Switching,Antigenic Diversity,Variation, Antigenic,Antigen Variation,Antigenic Switching,Antigenic Variability,Switching, Antigenic,Diversity, Antigenic,Switching, Antigen,Variability, Antigenic,Variation, Antigen
D012641 Selection, Genetic Differential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population. Natural Selection,Genetic Selection,Selection, Natural
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine.
October 1996, American journal of hematology,
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Naturally arising HIV-1 Nef variants conferring escape from cytotoxic T lymphocytes influence viral entry co-receptor expression and susceptibility to superinfection.
December 2010, Biochemical and biophysical research communications,
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
March 1998, Science (New York, N.Y.),
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.
July 2012, Blood,
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
HIV-specific cytotoxic T lymphocytes.
January 1989, Research in immunology,
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
December 1999, Clinical science (London, England : 1979),
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection.
December 1996, Proceedings of the National Academy of Sciences of the United States of America,
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.
January 1997, Springer seminars in immunopathology,
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
November 1993, AIDS research and human retroviruses,
G Haas, and U Plikat, and P Debré, and M Lucchiari, and C Katlama, and Y Dudoit, and O Bonduelle, and M Bauer, and H G Ihlenfeldt, and G Jung, and B Maier, and A Meyerhans, and B Autran
Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
March 1994, The Journal of clinical investigation,
Copied contents to your clipboard!